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Abstract 
We assessed the ameliorative effect of Virgin Coconut Oil following atrazine-induced metabolic derangement in rats. 
Adult male Wistar rats weighing 180-200g were used; randomly separated into two major groups. Thirty-five rats in the 
test group were randomly divided into five subgroups of 7 rats per sub-group and treated thus: Sub-group (SG) 1, 2, and 
3 received 10ml/kg of distilled water, 10ml/kg VCO, 123mg/kg of Atrazine respectively, SG4 was diabetic control; SG 5 was 
the diabetic group treated with 10ml/kg of VCO for 2 weeks, after which the animals were sacrificed, and blood collected 
for analysis. 35 rats for the recovery group were divided into 5 subgroups of 7 rats per sub-group and treated; SG 1, 2, 3, 
4, and 5 received 10ml/kg distilled water, 10ml/kg VCO, 123mg/kg of ATZ, respectively. After 2 weeks, the animals were 
re-treated thus: SG 1,2,3,4 and 5 received 10ml/kg of distilled water, 10ml/kg of VCO, 123mg/kg of ATZ, 10ml/kg VCO, 
and 10ml/kg distilled water, respectively. After 2 weeks, the animals were also sacrificed, and blood was collected for 
analysis. ATZ reduced serum insulin and caused a reduced expression of GLUT4. VCO restored GLUT4 levels but did not 
significantly restore the insulin to normal levels.
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IntroductIon
G lucose transporters are a large family of structurally related transport proteins that affect the entry of glucose molecules 
into the cell [1]. Three types of glucose 
transporters have been identified: sodium-
glucose-linked transporter or sodium-dependent 
glucose co-transporter (SGLUT), facilitated 
diffusion glucose transporters, or sodium-
dependent glucose transporters (GLUTS) and 
SWEETs [1, 2]. The GLUTs transport glucose 
across the plasma membrane by means of a 
facilitated diffusion mechanism [1].  GLUT4 
is the primary insulin-responsive glucose 
transporter found in the heart, skeletal muscles, 
adipose tissues, and brain. It belongs to class 
II of the GLUTs family of glucose transporters 
[1]. GLUT4 is a significant mediator of glucose 
removal from the circulation and a key regulator 
of the whole-body glucose homeostasis [3]. 
Expression and translocation (to tissue surface) 
of GLUT4 receptors are mainly regulated by 
insulin secretion. Contraction of skeletal and 
cardiac muscles also increases expression and 
translocation of GLUT4 expression (4). Reduced 
GLUT4 expression is notably associated with 
insulin resistance [5]. In its basal state, most of 
the GLUT4 is located within specialized vesicles. 
In response to insulin or contraction stimulation, 
most of the transporters are rapidly translocated 
to the plasma membrane, where they take up 
extracellular glucose into the cell and then are 
recycled and stored until new stimulation occurs 
[6].
There is an association between diabetes and 
Correspondence: Olatunbosun Titilope Helen, Department of Physiology, Faculty of Basic Medical Sciences, 
University of Uyo, P.M.B. 1017, Uyo. Akwa Ibom State, Nigeria. E-mail: expensivetiti@gmail.com
Int. J. Curr. Res. Physiol. Pharmacol. 2021;5(3):1-9 2
Olatunbosun et al. Atrazine derangement of GLUT-4 and Insulin metabolism and the ameliorative effect of Virgin coconut oil in male Wistar rats
GLUT4 concentration and responsiveness. Mice 
with type II DM have been indicated to have up 
to 70% reduction of GLUT4 in the cardiac muscle 
[7]. Oxidative stress was reported to cause 
oxidation and carbonylation near the glucose 
transport channel of GLUT4 transporters, thus 
leaving them dysfunctional; this dysfunction 
results in insulin resistance [8]. So, there seem 
to exist a two-way relationship between GLUT4 
and DM: reduced GLUT4 production/expression 
results in insulin resistance - although GLUT4 
polymorphism is rare, and mutations are 
more likely to occur in the elderly [9], and the 
mechanism of insulin resistance may result 
in an impaired translocation and expression 
of GLUT4 at various sites [10]. Translocation 
of GLUT4 to the cell surface is a significant 
part of the underlying molecular mechanism 
responsible for the insulin-mediated increased 
Vmax of glucose transport [1]). Transgenic 
manipulation of GLUT4 levels has revealed 
that GLUT4 is, indeed, rate-limiting for insulin-
dependent glucose uptake [12, 13]. 
Atrazine (ATZ), a persistent organic pollutant, is 
one of the most used herbicides worldwide and 
Nigeria [14].  People are exposed to ATZ in the 
air [15] (Mair, 1978), water [16], and food. The 
atrazine effect in humans and animals primarily 
involves the endocrine system. Studies suggest 
that Atrazine is an endocrine disruptor that 
can cause hormone imbalance [17]. ATZ has 
induced obesity and insulin resistance in rats 
by impairing mitochondrial function [18].
Studies suggest that Atrazine is an endocrine 
disruptor that can cause hormone imbalance 
[17]. Atrazine can suppress the expression 
of functional glucose transporter in several 
organs leading to excessive blood glucose levels 
because glucose could not be picked up by the 
cells for metabolism, which could ultimately 
lead to diabetes [18]. Atrazine also causes 
mitochondrial dysfunction [19], which would 
lead to a decrease in substrate oxidation. The 
reduced oxidation, particularly fatty acids, 
results in lipid accumulation, including 
deposition of metabolically active lipid mediators 
such as diacylglycerols and ceramides [20]. Both 
diacylglycerol and ceramides (DAG and CER) 
have been shown to inhibit insulin signaling. DAG 
through protein kinase c activation translocate 
to the plasma membrane and inhibits insulin 
receptor [21] and CER through inhibition of 
the protein kinase ART [22]. Therefore, DAG 
and CER accumulation are a plausible link 
between mitochondrial dysfunction and insulin 
resistance [20]. 
Virgin Coconut Oil (VCO) is unprocessed oil 
obtained from the mature and fresh kernel 
of the coconut fruit by mechanical or natural 
means, with or without mild heat [23]. VCO is 
rich in Lauric acid, an essential fatty acid that 
transforms into a compound - Monolaurin Acid 
that is believed to fight viral pathogens and 
protect the body from parasites [24]. VCO has 
been found to have hypoglycemic actions by 
enhancing insulin secretion and ameliorating 
oxidative stress-induced in type I Diabetes 
mellitus (DM) induced rats [25]. VCO was also 
found to ameliorate high-density lipoprotein 
levels in induced diabetic male rats [26]. As 
the regular determination of lipid levels and 
proper dieting is paramount in preventing 
the prevalence of certain risk factors (such as 
obesity) associated with DM [26], VCO’s effects 
on high-density fats may be beneficial to the 
management of and prevention of diabetes.
This study aims to evaluate the fasting blood 
glucose level, serum insulin level, and GLUT-




Adult male albino Wistar rats (180-200g body 
weight) were purchased and maintained at 
the animal house Unit of the Department of 
Physiology, Faculty of Basic Medical Sciences, 
University of Calabar. The animals were kept 
in a well-ventilated space to acclimatize for two 
weeks. The animals were fed with rat chow and 
allowed drinking water ad libitum. After the 
acclimatization period, the animals were weighed, 
their fasting blood glucose level was measured 
and reassigned before the commencement of the 
experimental treatment. The cages were cleared 
and kept clean throughout the experiment.
Experimental design and treatment of 
animals
We randomly assigned the thirty five (35) rats 
into two main groups named; the test group and 
recovery groups. The 35 rats in the test group 
were further assigned to five subgroups of seven 
rats each 
Sub-Group (SG)1 was normal control 
administered 10ml/kg body weight of distilled 
water, SG 2 was administered 10ml/kg of Virgin 
Coconut Oil (VCO), SG 3 was administered 
received 123mg/kg (20% of lethal dose) of 
Atrazine (ATZ), SG 4 was the diabetic control 
and were left untreated, and SG 5 was the 
diabetic group and was administered 10ml/kg 
of VCO once daily by oral gavage. Administration 
in the test group was for 2 weeks, then the rats 
were sacrificed and blood collected for analysis. 
Group 4 and 5 were made diabetic after being 
assigned to their sub-groups.
Simultaneously in the first 2 weeks’, thirty-
five rats for the recovery group were also sub-
divided into 5 sub-groups of 7 rats each: (SG) 
1 was normal control and was administered 
10ml/kg body weight of distilled water, SG 2 
was administered 10ml/kg of Virgin Coconut Oil 
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(VCO), SG 3, 4 and 5 were administered 123mg/
kg of ATZ. After the first 2 weeks, the animals 
were then re-treated for recovery as follows: (SG) 
1 was still administered 10ml/kg body weight of 
distilled water, SG 2 was also still administered 
10ml/kg of Virgin Coconut Oil (VCO), 123mg/kg 
of ATZ administration also continued in SG 3, 
while SG 4 was administered 10ml/kg of VCO, 
and SG 5 was administered 10ml/kg of distilled 
water. Recovery treatment also lasted for 2 
weeks, after which the animals were sacrificed 
and blood collected for analysis. 
Table 1. Experimental grouping and treatment
test Group (2 WeeKs)
GROUPS TREATMENT
Normal Control + H20 10ml/kg of distilled water 
(H2O)
Normal Control + VCO 10ml/kg of Virgin Coconut 
Oil (VCO)
Atrazine Treated 123mg/kg (20% of lethal 
dose) of Atrazine
Diabetic Control 10ml/kg of distilled water 
(H2O)
Diabetic +VCO 10ml/kg of Virgin Coconut 
Oil (VCO)
recovery Group (4 WeeKs)
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Induction of Diabetes mellitus (DM): Diabetes 
was induced intraperitoneally using 150mg/
kg body weight of alloxan monohydrate once 
[27, 28].  The diabetic state was observed from 
about 48 hours by the symptoms of polyuria and 
glucosuria. After 72 hours, DM was confirmed 
with a blood glucose level of 180-200mg/dL and 
above [25] using a glucometer (ACCU-CHECK 
Active) and ACCU-CHECK compatible glucose 
test strips.
Preparation of Virgin Coconut Oil (VCO): 
Mature dried coconuts were purchased from the 
local market, and VCO was extracted using the 
modified wet extraction method [29]. The solid 
endosperm of mature coconut was crushed and 
made into a thick slurry. About 500 ml of water 
was added to the slurry obtained and squeezed 
through a fine sieve to obtain coconut milk. The 
resultant coconut milk was left for about 18 
hours to facilitate the gravitational separation of 
the emulsion. Demulsification produced layers 
of an aqueous phase (water) at the bottom, an 
oil phase in the middle layer, and an emulsion 
phase (cream) on top. The cream on top was 
removed, and the oil was scooped and warmed 
for about 5 minutes to remove moisture. The oil 
obtained was then filtered and stored at room 
temperature.
Determination of fasting blood glucose: 
Fasting blood glucose was determined using 
ACCU-Check blood glucose meter with 
compatible glucose test strips according to 
prescribed instructions by pricking the tail tip 
and dropping blood gently on the test strip. This 
was done before the induction of diabetes and 
72 hours after induction; after which it was done 
weekly
Estimation of serum insulin concentration: 
The RayBio Rat Insulin ELISA kit (USA) was 
used for the determination of serum insulin 
concentration as used by Ghezzi et al. (2012) 
[30]. 
Assay Procedure: 100 μl of each standard and 
sample were pipetted into appropriate wells and 
covered; they were incubated for 2.5 hours at 
room temperature with gentle shaking. (The 
Insulin present in a sample will bind to the wells 
by the immobilized antibody). The solution was 
discarded, and 300 μl of the wash buffer was 
pipetted into each well and washed 4 times. After 
the last wash, the plate was inverted and blotted 
against clean paper towels. 100 μl of biotinylated 
anti-Rat Insulin antibody was then added to each 
well and incubated for 1 hour at room temperature 
(18-25°C) with gentle shaking. The solution was 
discarded, and wells washed as before to remove 
unbound biotinylated antibodies. 100 μl of HRP-
conjugated Streptavidin solution was added to 
each well and incubated for 45 minutes at room 
temperature (18-25°C) with gentle shaking. The 
solution was discarded and washed as before. 
100 μl of TMB One-Step Substrate Reagent was 
added to each well and incubated for 30minutes 
at room temperature in the dark with gentle 
shaking. The blue color developed in proportion 
to the amount of insulin bound. Lastly, 50 μl of 
Stop Solution was then added to each well which 
changes the color from blue to yellow, and the 
intensity of the color is measured at 450 nm.
Ethical Approval: Full ethical approval 
(022PY30417) was given by the Faculty Animal 
Research Ethics Committee, Faculty of Basic 
Medical Sciences, University of Calabar, Calabar, 
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Cross Rivers State. This was in accordance with 
the declaration of Helsinki (1964).
Statistical analysis
Statistical analysis was carried out using the 
windows SPSS package (SPSS 20.0). Data were 
analyzed using one-way ANOVA followed by 
Tukey’s post hoc test. Data were expressed as 
mean + standard error of the mean (Mean±SEM). 
Results with values of p<0.05 were considered 
significant.
results
Insulin levels (µIU/ml) in normal control, 
ATZ, and diabetic groups
The mean values for insulin are 14.94 ± 0.31, 
16.18 ± 0.16, 11.82 ± 0.31, 10.68 ± 0.41, and 
12.34 ± 0.12 for NC + H2O, NC + VCO, ATZ 
treated, Diabetic control, and Diabetic + VCO 
groups, respectively. In figure 1, there was a 
significant (p<0.05) increase in insulin levels 
in the NC + VCO group when compared to the 
NC + H2O. ATZ significantly (p<0.05) decreased 
insulin levels when compared with the NC + 
H2O and NC + VCO. Insulin level in the diabetic 
untreated group was significantly (p<0.05) lower 
than NC + H2O, NC + VCO and ATZ administered 
groups. VCO administration significantly 
(p<0.05) increased the insulin levels when 
compared with the diabetic untreated group but 
significantly (p<0.05) lower than the NC + H2O 
and NC + VCO groups
Fig 1. Comparison of Insulin levels in Control, 
ATZ and Diabetic groups.
Values are mean ± SEM. n=7.
a = p < 0.05 vs NC, b = p < 0.05 vs NC + VCO, c = 
p < 0.05 vs ATZ, d = p < 0.05 vs Diabetic control
Insulin levels in normal control and ATZ 
recovery groups
A significant (p<0.05) decrease was observed in 
mean insulin levels of the ATZ continued group 
(10.46±0.13) when compared with the NC + 
H2O (14.94±0.45) and NC + VCO (16.25±0.26) 
groups. There was a significant (p<0.05) increase 
with VCO administration in the VCO recovery 
group (11.65±0.16) when compared to the ATZ 
continued group, but there was no significant 
(p<0.05) difference between the insulin level in 
the VCO recovered and ATZ untreated group 
(11.13±0.12) (Figure 2).
Fig 2. Comparison of Insulin levels in Control, 
ATZ Continued and Recovery Groups.
Values are mean ± SEM. n=7.
a = p < 0.05 vs NC, b = p < 0.05 vs NC + VCO, 
c = p < 0.05 vs ATZ continued, d = p < 0.05 vs 
VCO recovered
GLUT4 levels (ng/ml) in normal control, ATZ 
and diabetic groups
Figure 3 shows the mean levels of GLUT4 in the 
experimental groups, which are 97.32±0.51, 
142.86±0.99, 78.64±0.35, 74.82±0.37, and 
95.99±0.37 for NC + H2O, NC + VCO, ATZ 
treated, Diabetic control, and Diabetic +VCO 
groups, respectively.  GLUT4 levels were found to 
be significantly (p<0.05) higher in the NC + VCO 
group than in the NC + H2O group. The GLUT4 
level in the ATZ treated group was significantly 
(p<0.05) lower than that of the NC + VCO and 
NC + H2O group. GLUT4 level in the diabetic 
untreated group was significantly (p<0.05) lower 
than that of the ATZ-treated group, the NC + 
VCO group, and the NC + H2O group. In the 
diabetic VCO-treated group, their GLUT4 level 
was significantly (p<0.05) higher than that of the 
diabetic untreated and ATZ-treated groups but 
significantly (p<0.05) lower than the NC + VCO 
group and not significantly (p<0.05) different 
from the NC + H2O. 
 
Fig 3. Comparison of Insulin levels in Control, 
ATZ and Diabetic groups.
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Values are mean ± SEM. n=7.
a = p < 0.05 vs NC, b = p < 0.05 vs NC + VCO, c = 
p < 0.05 vs ATZ, d = p < 0.05 vs Diabetic control
GLUT4 levels in the normal control and ATZ 
recovery groups
Figure 4 showed that the GLUT4 levels was 
significantly (p<0.05) lower in ATZ continued 
group with mean values of 77.39±0.79 when 
compared with the NC + H2O (97.06±0.57) and 
NC + VCO (142.46±1.12) groups. The mean 
values of GLUT4 in the VCO recovered group 
(111.66±0.76) was significantly (p<0.05) higher 
than the NC + H2O group and ATZ continued 
group but significantly (p<0.05) lower than 
the NC + VCO group. In the untreated group 
(102.53±0.53), GLUT4 level was significantly 
(p<0.05) lower than the NC + VCO and VCO 
recovered group, but significantly (p<0.05) 
higher than ATZ continued group; though not 
significantly different from the NC + H2O group.
 
Fig 4. Comparison of Estradiol levels in 
Control, ATZ Continued and Recovery Groups.
Values are mean ± SEM. n=7.
a = p < 0.05 vs NC, b = p < 0.05 vs NC + VCO, 
c = p < 0.05 vs ATZ continued, d = p < 0.05 vs 
VCO recovered
dIscussIon
The FBG (fasting blood glucose) concentration 
of the NC+H2O and NC+VCO groups was 
not significantly different at the end of the 
experiment’s first phase. This supports the 
report by Eleazu et al. (2019) [31], which showed 
no significant change in FBG concentration of 
the VCO group comparable to the NC+H2O 
group. The non-effect of VCO administration 
had on the FBG concentrations of the NC+VCO 
concerning the NC+H2O group suggests that 
VCO did not negatively impact their blood glucose 
concentrations [31]. Triggering the production 
of reactive oxygen species (ROS), which in 
turn cause the destruction of the beta cells 
and eventually result in a condition of insulin-
dependent diabetes, has been documented as 
the primary mechanism of action of alloxan-
induced diabetes [32]. Thus, an alloxan-diabetic 
model is used to investigate diabetes arising from 
beta-cell destruction caused by ROS [25]. The 
primary marker of DM is hyperglycemia owing 
to a decrease in pancreatic insulin secretion or 
defective insulin action and insulin resistance 
by target cells [33].  Type 1 DM results from 
idiopathic or cellular-mediated autoimmune 
destruction of pancreatic β- cells; patients 
thus depend totally on exogenous insulin 
[34]. Following alloxan injections, a significant 
increase in FBG of alloxan-induced diabetic 
animals in comparison to NC+H2O, NC+VCO, 
and ATZ rats was noted. Similarly, several 
studies have documented a marked increase in 
blood glucose levels following alloxan induction 
[25, 31, 35, 36, 37]. It was observed that 
treatment of the diabetic group with 10ml/kg of 
VCO for two weeks brought about a significant 
drop in fasting blood glucose levels. This further 
supports the hypoglycemic ability of VCO [38, 
39]. Several other studies have also reported 
the hypoglycemic effect of VCO on alloxan-
induced diabetic rats [25, 31, 37]. This beneficial 
potential of VCO on blood glucose level was 
attributed to its antioxidant ability [25]. Ngala 
and co-workers (2016) [40] observed that the 
administration of the coconut oil diet to diabetic 
mice significantly reduced blood glucose, which 
could be mediated through its antioxidant effect 
[40]. A study demonstrated that administering 
coconut oil prevented diabetes [41]. According 
to our report, a significant elevation of fasting 
blood glucose occurred in ATZ treated group 
comparable to NC+H2O and NC+VCO groups 
but the level diminished concerning the diabetic 
untreated group. This probably showed that 
ATZ does not have a hyperglycemic effect on 
the fasting blood glucose for the 14 days, i.e., 
the fasting blood glucose level was still below 
120mg/dl. This supports the report by Lim et al. 
(2009) [18], where FBG levels of rodents treated 
with ATZ and placed on a regular diet increased 
compared to the controls. Jestadi and co-workers 
(2014) [42] recorded a significant increment in 
FBG levels in diabetic untreated, and diabetic 
rats administered ATZ comparable to control 
rats; nevertheless, no significant difference in 
FBG concentration occurred comparing diabetic 
untreated and diabetic rats administered ATZ, 
showing that ATZ did not further aggravate the 
diabetic blood glucose during the two weeks’ 
experimentation period. In the recovery group, 
the consistent elevation of the FBG concentration 
in the ATZ continued group was recorded; 
the fasting blood glucose level increased to a 
hyperglycemic level (125mg/dl-140mg/dl) but 
not up to the diabetic level (>140mg/dl) relative 
to this research.  A significant reduction in 
FBG levels in the atrazine sub-group that was 
administered VCO compared with the other 
groups was observed. As a result of this, our 
report suggests that VCO has a mitigating effect 
on Atrazine induced hyperglycemia.
Insulin causes a decrease in blood glucose by 
enhancing amino acids, glucose, and fats take-
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up and storage after a meal; hence, a decline in 
the INL level in the plasma results in an increase 
in blood sugar. The primary marker of DM is 
hyperglycemia, which decreases pancreatic 
secretion of insulin or defective insulin action, 
i.e., insulin resistance by target cells [33]. 
Lauric oil, one of the components in VCO, 
has been documented to have insulinotropic 
potentials [25]. In the NC+VCO groups, a 
significant increment in insulin levels was 
recorded concerning the NC+H2O group. The 
high insulin level seen in this group might be 
because of lauric acid in the VCO. A significant 
decline in insulin concentration occurred in ATZ 
and diabetic untreated group comparable to the 
control group. Reports of several researchers 
have shown that alloxan exerts a cytotoxic 
effect on pancreatic β cells, resulting in Type 1 
diabetes mellitus [35, 36]. The mechanism of 
cytotoxic activity of alloxan on beta cells has 
to do with essential sulphydryl (-SH) group 
oxidation, glucokinase blockade, generation of 
toxic ROS, and cellular calcium homeostasis 
imbalance [36]. The resulting damage to β-cells, 
responsible for the reduced insulin secretion, 
results in a decrease in insulin release and the 
attendant hyperglycemia with metabolic and 
other associated diabetic complications. The fall 
in insulin level of the alloxan-induced diabetic 
animals observed in this study is similar to the 
reports by Iranloye et al. (2013) [36] and Udia et 
al. (2016) [43], who also observed a significant 
fall in serum insulin concentration of alloxan 
initiated diabetic rodents. Lack of insulin in 
DM is associated with diabetic complications, 
reversed or arrested when DM is appropriately 
managed with insulin injections or oral 
hypoglycaemic agents [44]. With VCO treatment 
in the Diabetic+VCO group, we observed a 
significant elevation in insulin concentration 
compared to diabetic untreated rats, though 
significantly less compared with the control 
groups, no significant change in comparison to 
ATZ treated groups. This supports the findings 
of Iranloye and colleagues (2013) [25] where they 
also recorded an increment in serum insulin in 
diabetic rodents treated with 10 ml/kg BW dose 
of VCO but a non-significant elevation of insulin 
levels in diabetic rodents administered 7.5 ml/
kg body weight was observed. They concluded 
that the ineffectiveness of 7.5 ml/kg body weight 
and effectiveness of 10 ml/kg BW doses of VCO 
on serum insulin shows that the effect of VCO 
on glucose homeostasis is dose-dependent. 
Ngala et al. (2016) [40] reported on the effect 
of coconut oil alone and glibenclamide plus 
coconut oil alone in diabetic mice treatment. 
They observed that coconut oil has a synergistic 
effect on glibenclamide action. The hypoglycemic 
impact of the co-administration of glibenclamide 
and coconut oil was drastically higher than the 
impact of coconut alone. They reasoned that 
coconut oil could consequently incite insulin 
discharge which can potentiate the insulin 
release actuated by the drug glibenclamide or 
enhances insulin sensitivity. Though serum 
insulin level was significantly boosted in VCO 
treated rats compared to the diabetic untreated 
group, its level was reduced concerning NC+H2O; 
we also infer that probably if VCO was used for a 
more extended period, the insulinotropic effects 
could be more evident. The study has revealed 
a significant (p<0.001) increment in plasma 
insulin level in alloxan-administered rodents 
treated with leaf extracts of Rothmannia hispida 
comparable to control rodents and diabetic non-
treated rodents [43]. They proposed that the 
increased insulin levels noted in their study 
resulted from the ability of the phytochemicals in 
Rothmannia hispida to stimulate insulin release, 
inhibit insulin breakdown, and/or regenerate 
pancreatic β-cells that were damaged by alloxan 
in the diabetic state. We also propose that the 
constituents or lauric acid present in VCO could 
have also stimulated insulin synthesis, release 
and inhibited insulin breakdown. 
GLUT4 is a noteworthy transporter of glucose 
into the tissues and principal controller of the 
entire homeostasis of glucose [3]. Expression 
and translocation (to tissue surface) of GLUT4 
receptors are mainly regulated by insulin 
secretion.  GLUT4 plays a significant role 
in insulin-stimulated glucose uptake and 
utilization in skeletal muscles [45]. Insulin also 
increases the expression of GLUT4 in the target 
cells [46] and stimulates its translocation to the 
plasma membrane for the uptake of glucose [12]. 
In muscle, insulin facilitates the transportation 
of glucose by GLUT4, stimulates glycogen 
production and glycolysis.
Furthermore, it also enhances glucose uptake 
in the adipose tissue, and thus all maintain 
glucose metabolism. The results from the test 
group indicated a significant decrease of GLUT4 
in diabetes-induced groups, compared to the 
control groups; this is similar to the investigation 
by Maria and co-workers (2013) [47], where they 
reported that the levels of GLUT4 reduced by up 
to 70% in diabetic mice compared with normal 
ones. Tsao et al. (1999) (48) also generated a type II 
diabetes experimental mouse model by a genetic 
interruption in one allele of GLUT4 in muscle 
and fat tissue, which prompts hyperglycemia 
and hyperinsulinemia; this demonstrated that 
a defect in GLUT4 might contribute to insulin 
resistance. The pesticide has been documented 
to reduce the expression of glucose transporters 
proteins in several organs, hypothesized to be the 
possible association between them and insulin 
disruption [49]. GLUT4 level in the ATZ-treated 
group was observed to be significantly lower 
than that of the control group. This reduction of 
GLUT4 in rats treated with ATZ could be due to 
Atrazine’s oxidative properties because ATZ was 
found to suppress antioxidant enzyme defenses 
in rodents. Oxidation has been reported to 
induce carboxylation of the glucose transport 
channel of GLUT4, making them dysfunctional 
(8). From these results, it is reasonable to infer 
that Atrazine may, in the long-term, induce 
insulin resistance by causing dysfunction or a 
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decrease in GLUT4 expression. This corresponds 
with the work of Lim et al. (2009) [18], where the 
insulin sensitivity index (ISI) was reported to be 
significantly lowered to an average of 4.35 for the 
ATZ treated group concerning 6.1 in controls. 
The decreased expression of GLUT4 levels and 
defect in GLUT4 trafficking may participate in the 
pathogenesis of hyperglycemia and are notably 
connected with insulin resistance [5]. Alloxan-
induced diabetes and ATZ notably caused a 
decreased expression of GLUT4, which could be 
linked to the diabetic and hyperglycemic fasting 
blood glucose levels observed in the present 
research. The result revealed a significant 
increment in levels of GLUT4 in the NC+VCO 
group compared with the NC+H2O group; this 
increase might be because of VCO’s antioxidative 
properties [50]. It was discovered that vanadium 
could increase GLUT4 expression in diabetic 
animals, but whether this occurs through direct 
interaction with the GLUT4 promoter or through 
a yet unknown pathway was not elucidated. 
VCO can also increase the GLUT4 expression in 
diabetic animals, and this may at least partially 
explain the glucoregulatory effects of VCO. The 
recovery group observed that the GLUT4 level 
in the VCO recovery group was significantly 
elevated concerning ATZ continued and 
untreated groups. Its GLUT4 level was elevated 
significantly than that of the NC+H2O group. It 
can thus be said that VCO can restore GLUT4 
levels in rats exposed to ATZ. This increase 
in GLUT4 could be due to VCO antioxidative 
properties on tissues that express GLUT4. This 
antioxidative action may have allowed for the 
expression of the transporter, which had been 
rendered dysfunctional by ATZ and diabetes. 
The overall effect of this would be a decrease in 
blood glucose level, which corresponds with the 
work of Iranloye et al. (2013) [25] considerably 
diminished in diabetic rodents that received 
VCO (for four weeks) than diabetic untreated 
rats [25]. GLUT4 concentration in the untreated 
group was observed to be elevated than that 
of the ATZ-continued group. From this, it is 
reasonable to infer that withdrawal of ATZ from 
the animals led to a decrease in GLUT4 levels. 
Nevertheless, it is critical to highlight that the 
GLUT4 level of these rats was lesser compared 
with VCO-treated recovery rats.
conclusIon
Insulin is the dominant glucoregulatory hormone. 
The fasting state regulates the plasma glucose 
concentration primarily by restraining hepatic 
glucose production; higher concentrations, 
such as those found after meals, are required 
to stimulate glucose utilization [51]. GLUT4 
is a significant mediator of glucose removal 
from the circulation and a key regulator of the 
whole-body glucose homeostasis [3]. Expression 
and translocation (to tissue surface) of GLUT4 
receptors are mainly regulated by insulin 
secretion. This study has shown and confirmed 
the deleterious effects of  atrazine and diabetes 
on glucose metabolism by reducing serum 
insulin and causing areduced expression of 
GLUT4. VCO restored GLUT4 levels but did not 
significantly restore the insulin to normal levels. 
Probably if used for a more extended period, the 
effects might be more pronounced.
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